OCTOBER 17, 2011 – Pittsburgh, PA – invivodata inc.®, the industry leader in patient reported outcomes (PRO) solutions and services for global clinical research, along with its scientific and regulatory consulting division, PRO Consulting®, today announced the successful conclusion of its PROficiency™ Fall Conference Series. Throughout the past month, hundreds of biopharma and medical device researchers attended seven conferences across the US and Europe to obtain current, practical information on the effective use of PRO throughout all stages of clinical research.
The series drew representatives from over 80 biopharmaceutical companies, ranging from small biotech organizations to 9 of the world’s top 10 pharmaceutical companies. Attendees participated in case studies and presentations by international biopharmaceutical professionals and industry experts sharing real-world experience with successful PRO concepts, strategy, implementation, and regulatory submission. Upon completing one of the conferences, an International Payer Strategy Leader at Genentech commented “Very knowledgeable speakers and lots of valuable information on PRO development and implementation relevant to those in clinical development roles.”
“We’re extremely pleased with the outcome of this series,” said Dr. Jean Paty, invivodata Co-founder and Chief Scientist and Regulatory Advisor of PRO Consulting. “Our intent was to provide a forum for researchers to network and learn from leading PRO experts, advance their knowledge of the scientific and regulatory considerations of capturing the patients’ perspective in clinical development, and receive practical input that they could use day-to-day in their clinical research.” Post-conference surveys indicated that 96% of attendees said the knowledge gained from the meeting would make them more effective in their job. After participating in the series, an Associate Clinical Program Director from Astellas Pharma Europe remarked, “Great meeting! Very informative, good discussions, some new insights gained…truly back to the patient!”
invivodata’s fall conference series was an extension of PROficiency 2011 – its ongoing educational initiative focused on PROs in clinical research. To download replays of recently held programs and for information on upcoming PROficiency educational events, visit www.invivodata.com/eweb.
About invivodata
invivodata is the only fully-integrated PRO Solutions Organization delivering regulatory-proven strategic consulting and practical ePRO solutions to biopharmaceutical companies who depend upon patient-centered research. From crafting PRO measurement strategy to collecting PRO data electronically, invivodata helps its customers strategically use patient reported data to support labeling claims, enhance market access, and meet other clinical program objectives. Through partnerships with leading CROs and eClinical technology providers, invivodata seamlessly integrates into the clinical trial ecosystem, helping to minimize operational risk and maximize efficiencies. invivodata’s solutions have been used in over 350 clinical programs and are built upon the industry-leading ePRO system in delivering primary efficacy data for global drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, PA., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, CA., USA. For more information, visit www.invivodata.com.
About PRO Consulting
PRO Consulting, a division of invivodata, inc., provides consulting services to help clinical research teams effectively develop, execute, and document patient reported outcome (PRO) strategies to support their clinical research objectives. The PRO Consulting team has worked on over 150 clinical studies in 50+ indications, has more than 265 years of cumulative experience in psychometrics, PRO study design, and migrating and validating electronic solutions to collect PRO data, and has extensive experience working with the FDA and other regulatory bodies. For more information please visit www.patientreported.com
